RIGEL PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -59.0% | -35.6% | -10.7% |
| FY2022 | 430.2% | -222.0% | -43.6% |
| FY2023 | 87.6% | -80.0% | -21.4% |
| FY2024 | 531.8% | 27.6% | 10.7% |
| FY2025 | 93.8% | 82.7% | 71.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -59.0% | -35.6% | -10.7% |
| FY2022 | 430.2% | -222.0% | -43.6% |
| FY2023 | 87.6% | -80.0% | -21.4% |
| FY2024 | 531.8% | 27.6% | 10.7% |
| FY2025 | 93.8% | 82.7% | 71.5% |